This study was to investigate the quinolone resistance to gram negative bacteria isolated in the First Bethune Hospital during the past 8 years. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed by WHONET 5 software according to Clinical and Laboratory Standards Institute(CLSI). The rates of extended spectrum beta-lactamases ESBLs in Escherichia coli and Klebsiella.spp were 43.6 ~60.1 and 51.0 ~65.1 during the past 8 years, respectively. In recent 8 years, the quinolone resistance to gram negative bacteria had increased. In particular, Escherichia coli resistant to quinolones was more obvious. Monitoring of the quinolone resistance to gram negative bacteria should be strengthened. The change of the antimicrobial resistance should be investigated in order to guide direct rational drug usage in the clinic and prevent bacterial strain of drug resistance from being transmitted.
Introduction
High prevalences of quinolone resistance in enterobacteria, particularly in Escherichia coli, have been described in America and Asia [1] [2] . In Escherichia coli and klebsiella, quinolone resistance has been more frequently found among strains producing plasmid-mediated ESBLs than among ESBLs-negative strains, which maybe related to the coordinated expression of several mechanisms of resistance.The objectives of this study were to investigate the quinolone resistance to gram negative bacteria in 8 consecutive years in our hospital.
Materials And Methods

Bacterial isolates
Consecutive nonduplicate nosocomial isolates of gram negative bacteria were collected during the period from 2003 to 2010 in our hospital. Isolates were identified at the species level using standard biochemical tests and microbiological methods.
Antimicrobial susceptibility testing
The susceptibilities of gram negative bacteria to 3 quinolone agents were determined by the disk diffusion method in accordance with the Clinical and Laboratory Standards Institute(CLSI) guidelines.
Detection of ESBLs production
ESBLs production was detected using the double-disk synergy (DDS) test. ESBLs presence was assayed using the following antibiotic disks (OXOID): cefotaxime (30 g), cefotaxime/clavulanic acid (30/10 g), ceftazidime (30 g), and ceftazidime/clavulanic acid (30/10 g). A 5-mm increase in a zone diameter for either antimicrobial agent tested in combination with clavulanic acid vs its zone when tested alone was ESBLs production. Klebsiella pneumoniae ATCC 700603 and Escherichia coli ATCC 25922 and ATCC 35218 strains served as quality controls. 
Results
The rates of ESBLs in
Discussion
The current study showed prevalence of ESBLs-production range from 51.0 65.1 ,43.6% 60.1% in Klebsiella.spp and Escherichia coli in our hospital, respectively. The resistance rates of ESBLs-producing Klebsiell.spp to quinolone were much higher than those of non-ESBLs-producing Klebsiell.spp and Escherichia coli in 8 consecutive years in our hospital. ESBLs producers are commonly resistant to different antibiotic families including quinolones. Our study showed the resistance rates of pseudomonas aeruginosa and Acinetobacter baumanii to quinolone were also very high in our hospital.
Broad use of quinolones has been followed by emergence of resistance, which has been due mainly to chromosomal mutations in genes encoding the subunits of the drug target enzymes, DNA gyrase and topoisomerase IV, and in genes that affect the expression of diffusion channels in the outer membrane and multidrug-resistance efflux systems. Recently, qnr genes, aac(6 )-Ib-cr gene, quinolone efflux pump protein QepA have involved. The mainly reason for high resistance to quinolone is the selection and persistence of multidrug-resistant ESBLs strains and plasmids in both clinical and community settings [3] .It is alerted that too much quinolone have been used in China.
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, cut costs and delay the emergence of resistant organisms. 
